icrf 193 has been researched along with genistein in 1 studies
Studies (icrf 193) | Trials (icrf 193) | Recent Studies (post-2010) (icrf 193) | Studies (genistein) | Trials (genistein) | Recent Studies (post-2010) (genistein) |
---|---|---|---|---|---|
155 | 0 | 30 | 7,423 | 204 | 2,311 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cao, L; Deng, CX; Tominaga, Y; Wang, A; Wang, RH; Wang, X | 1 |
1 other study(ies) available for icrf 193 and genistein
Article | Year |
---|---|
Genistein inhibits Brca1 mutant tumor growth through activation of DNA damage checkpoints, cell cycle arrest, and mitotic catastrophe.
Topics: Animals; Antineoplastic Agents; BRCA1 Protein; Breast Neoplasms; Cell Cycle; Cell Death; Cell Line, Tumor; Cell Proliferation; Chromosome Aberrations; Diketopiperazines; DNA Damage; Gene Expression Regulation, Neoplastic; Genistein; Mice; Mitosis; Mutation; Piperazines; Polyploidy; Topoisomerase II Inhibitors | 2007 |